RxDoctor Payments Data

Danielle Reed

Physician Assistant · Parkersburg, WVNPI 1093499956

Payments from drug & device makers

$1,468in general payments, 2019–2025

Across 76 payments — averaging $19.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$266
  • Boehringer Ingelheim$260
  • Bayer$182
  • Pfizer$175
  • Kestra Medical Technology Services, Inc.$145
  • Johnson & Johnson$121
  • plus $319 from 9 others

What the payments were for

  • Food & beverage$1,468100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,468 in reported general payments places this provider in the 80th percentile of 833 physician assistant providers in West Virginia.

See all physician assistant providers in West Virginia

Medicare billing

Part B allowed, 2024
$55,401
Medicare patients
339
Services billed
725

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban75$78,946
EntrestoSacubitril/Valsartan35$50,629
JardianceEmpagliflozin18$22,521
Repatha SureclickEvolocumab16$15,463
FarxigaDapagliflozin Propanediol11$14,611
Ranolazine ErRanolazine22$1,366
Metoprolol Succinate119$1,229
Isosorbide Mononitrate ErIsosorbide Mononitrate102$961
Ezetimibe41$714
Nitroglycerin62$555
Spironolactone63$507
Losartan Potassium46$442
Carvedilol42$440
Diltiazem 24hr Er (Cd)Diltiazem Hcl22$327
Atorvastatin Calcium46$322

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$175$78,94675 claims
NovartisEntresto$266$50,62935 claims
Boehringer IngelheimJardiance$260$22,52118 claims
AstraZenecaFarxiga$42$14,61111 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 833 physician assistant providers in West Virginia.

Other physician assistant in Parkersburg

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →